{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T00:38:09Z","timestamp":1791506289036,"version":"4.3.4"},"reference-count":19,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,13]],"date-time":"2025-08-13T00:00:00Z","timestamp":1755043200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100009076","name":"University of Science and Technology of China","doi-asserted-by":"publisher","award":["2024-RE-478"],"award-info":[{"award-number":["2024-RE-478"]}],"id":[{"id":"10.13039\/501100009076","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010814","name":"Anhui Provincial Department of Education","doi-asserted-by":"publisher","award":["2024AH052060"],"award-info":[{"award-number":["2024AH052060"]}],"id":[{"id":"10.13039\/501100010814","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.jneuroim.2025.578712","type":"journal-article","created":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T22:08:11Z","timestamp":1754431691000},"page":"578712","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Efficacy of FcRn antagonist efgartigimod in the treatment of Miller-Fisher\/Guillain-Barr\u00e9 overlap syndrome: Two case reports"],"prefix":"10.1016","volume":"407","author":[{"given":"Tingting","family":"Fan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jneuroim.2025.578712_bb0005","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/S1474-4422(24)00309-0","article-title":"Safety, tolerability, and efficacy of subcutaneous efgartigimod in patients with chronic inflammatory demyelinating polyradiculoneuropathy (ADHERE): a multicentre, randomised-withdrawal, double-blind, placebo-controlled, phase 2 trial","volume":"23","author":"Allen","year":"2024","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jneuroim.2025.578712_bb0010","series-title":"Bilateral Vocal Cord Paralysis in Miller Fisher Syndrome\/Guillain-Barre Overlap Syndrome and a Review of Previous Case Series","author":"Bahk","year":"2021"},{"key":"10.1016\/j.jneuroim.2025.578712_bb0015","doi-asserted-by":"crossref","DOI":"10.1111\/ene.16365","article-title":"Guillain-Barr\u00e9 syndrome: a comprehensive review","volume":"31","author":"Bellanti","year":"2024","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.jneuroim.2025.578712_bb0020","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1007\/s13760-022-02111-y","article-title":"A rare overlap between Miller Fisher syndrome and pure motor Guillain\u2013Barre syndrome","volume":"123","author":"Boutros","year":"2023","journal-title":"Acta Neurol. Belg."},{"key":"10.1016\/j.jneuroim.2025.578712_bb0025","doi-asserted-by":"crossref","DOI":"10.11604\/pamj.2024.47.127.42985","article-title":"Navigating the complexity of Guillain-Barr\u00e9 syndrome and Miller-Fisher syndrome overlap syndrome: a pediatric case report","volume":"47","author":"Chafiq","year":"2024","journal-title":"Pan Afr. Med. J."},{"key":"10.1016\/j.jneuroim.2025.578712_bb0030","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1007\/s10072-024-07300-6","article-title":"Only anti-GM4 antibody positivity in a Chinese girl with overlapping MFS\/GBS: a case report","volume":"45","author":"Chen","year":"2024","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.jneuroim.2025.578712_bb0035","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000038890","article-title":"Clinical presentation and symptomatology of Guillain-Barr\u00e9 syndrome: a literature review","volume":"103","author":"Elendu","year":"2024","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jneuroim.2025.578712_bb0040","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/S1474-4422(21)00159-9","article-title":"Safety, efficacy, and tolerability of efgartigimod in patients with generalised myasthenia gravis (ADAPT): a multicentre, randomised, placebo-controlled, phase 3 trial","volume":"20","author":"Howard","year":"2021","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jneuroim.2025.578712_bb0045","doi-asserted-by":"crossref","first-page":"e542","DOI":"10.1097\/WNO.0000000000001976","article-title":"GQ1b seropositive Guillain\u2013Barr\u00e9\/miller fisher overlap syndrome after pembrolizumab treatment","volume":"44","author":"Hunt","year":"2024","journal-title":"J. Neuroophthalmol."},{"key":"10.1016\/j.jneuroim.2025.578712_bb0050","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1097\/CND.0000000000000451","article-title":"Neonatal Fc receptor inhibitor therapeutics in neuromuscular disease","volume":"24","author":"Jaffry","year":"2023","journal-title":"J. Clin. Neuromuscul. Dis."},{"key":"10.1016\/j.jneuroim.2025.578712_bb0055","doi-asserted-by":"crossref","DOI":"10.1080\/21645515.2022.2125753","article-title":"Miller-Fisher syndrome and Guillain\u2013Barre syndrome overlap syndrome following inactivated COVID-19 vaccine: case report and scope review","volume":"18","author":"Liang","year":"2022","journal-title":"Hum. Vaccin. Immunother."},{"key":"10.1016\/j.jneuroim.2025.578712_bb0060","article-title":"An overlapping case of miller fisher syndrome and the pharyngeal-cervical-brachial variant of Guillain-Barr\u00e9 syndrome","volume":"12","author":"Martins","year":"2020","journal-title":"Eur. J. Case Rep. Intern. Med."},{"key":"10.1016\/j.jneuroim.2025.578712_bb0065","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s11940-020-0616-8","article-title":"Newer immunotherapies for the treatment of acute neuromuscular disease in the critical care unit","volume":"22","author":"Patel","year":"2020","journal-title":"Curr. Treat. Options Neurol."},{"key":"10.1016\/j.jneuroim.2025.578712_bb0070","doi-asserted-by":"crossref","first-page":"273","DOI":"10.3988\/jcn.2021.17.2.273","article-title":"Determining the utility of the Guillain-Barr\u00e9 syndrome classification criteria","volume":"17","author":"Tan","year":"2021","journal-title":"J. Clin. Neurol."},{"key":"10.1016\/j.jneuroim.2025.578712_bb0075","first-page":"653","article-title":"Miller-Fisher syndrome: a case report and review of the literature","volume":"4","author":"Truong","year":"2020","journal-title":"Clin. Pract. Cases Emerg. Med."},{"key":"10.1016\/j.jneuroim.2025.578712_bb0080","doi-asserted-by":"crossref","first-page":"3646","DOI":"10.1111\/ene.16073","article-title":"European academy of neurology\/peripheral nerve society guideline on diagnosis and treatment of Guillain\u2013Barr\u00e9 syndrome","volume":"30","author":"Van Doorn","year":"2023","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.jneuroim.2025.578712_bb0085","doi-asserted-by":"crossref","DOI":"10.1080\/21645515.2023.2215153","article-title":"Progress in Guillain\u2013Barr\u00e9 syndrome immunotherapy\u2014a narrative review of new strategies in recent years","volume":"19","author":"Yao","year":"2023","journal-title":"Hum. Vaccin. Immunother."},{"key":"10.1016\/j.jneuroim.2025.578712_bb0090","doi-asserted-by":"crossref","first-page":"3506","DOI":"10.1007\/s00415-024-12321-4","article-title":"Efgartigimod in the treatment of Guillain\u2013Barr\u00e9 syndrome","volume":"271","author":"Zhang","year":"2024","journal-title":"J. Neurol."},{"key":"10.1016\/j.jneuroim.2025.578712_bb0095","article-title":"AntiGQ1b antibody positive with MFS\/GBS overlapped syndrome with diplopia and hemiplegia onset: case report and retrospective analysis","volume":"101","author":"Zhao","year":"2022","journal-title":"Medicine (Baltimore)"}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572825001936?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572825001936?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,24]],"date-time":"2026-05-24T09:49:39Z","timestamp":1779616179000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572825001936"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":19,"alternative-id":["S0165572825001936"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2025.578712","relation":{},"ISSN":["0165-5728"],"issn-type":[{"value":"0165-5728","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy of FcRn antagonist efgartigimod in the treatment of Miller-Fisher\/Guillain-Barr\u00e9 overlap syndrome: Two case reports","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2025.578712","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"578712"}}